Clinical trials
Completed Arthritis, Rheumatoid trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
677 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 9 |
| 2001 | 13 |
| 2002 | 16 |
| 2003 | 21 |
| 2004 | 16 |
| 2005 | 38 |
| 2006 | 26 |
| 2007 | 41 |
| 2008 | 31 |
| 2009 | 48 |
| 2010 | 46 |
| 2011 | 53 |
| 2012 | 39 |
| 2013 | 33 |
| 2014 | 26 |
| 2015 | 25 |
| 2016 | 52 |
| 2017 | 19 |
| 2018 | 16 |
| 2019 | 21 |
| 2020 | 19 |
| 2021 | 21 |
| 2022 | 15 |
| 2023 | 10 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 677 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 56 |
| Bristol-Myers Squibb | 39 |
| Hoffmann-La Roche | 25 |
| Brigham and Women's Hospital | 20 |
| Eli Lilly and Company | 16 |
| Amgen | 15 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 15 |
| UCB Pharma | 13 |
| AbbVie | 12 |
| Sanofi | 11 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 677 |
| Arthritis | 69 |
| Osteoarthritis | 62 |
| Autoimmune Diseases | 21 |
| Arthritis, Psoriatic | 20 |
| Joint Diseases | 20 |
| Osteonecrosis | 18 |
| Lupus Erythematosus, Systemic | 17 |
| Pain | 15 |
| Crohn Disease | 13 |
Trials
Showing 1 to 25 of 677. Each trial links to its page on Pharma Observatory.
577 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.